Christopher M. Mullin

TL;DR: The efficacy of percutaneous closure of the LAA with this device was non-inferior to that of warfarin therapy and there was a higher rate of adverse safety events in the intervention group than in the control group, which were mainly a result of periprocedural complications.

TL;DR: In this article, the authors investigated whether an alternative technology using endovascular ultrasound renal denervation reduces ambulatory blood pressure in patients with hypertension in the absence of antihypertensive medications.

TL;DR: This individual patient data meta-analysis, based on the most complete available data set of mortality events from PTXD randomized controlled trials, identified an absolute 4.6% increased mortality risk associated withPTXD use.

TL;DR: There was a significant improvement in QOL in patients randomized to device for total physical score, physical function, and in physical role limitation compared to control, and larger gains were seen with the warfarin naive subgroup with a 12-month change.

TL;DR: History of AF at the time of ICD implant identifies additional risk of HF and death and the relationship between newly detected AF and inappropriate ICD shock or HF hospitalization is uncertain and requires further study.